Trial Profile
An Open-Label Prospective, Non-Randomized, International, Multi-center, Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) in Patients Suspected of Coronary Artery Disease (CAD)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 29 Aug 2014
Price :
$35
*
At a glance
- Drugs Flurpiridaz F 18 (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- Sponsors Lantheus Medical Imaging
- 29 Aug 2014 New trial record